Ivan Hyep

Chief Financial Officer, Bicara Therapeutics Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.6M

Companies

Latest trade

Aug 10, 2026

Companies

Bicara Therapeutics Inc.Chief Financial Officer −$3.2M

Trades

BCAX Sold 12,500 shares at $27.97 · planned $0.3M Aug 10

BCAX Sold 28,000 shares at $28.84 · planned $0.8M Jul 8

BCAX Sold 9,200 shares at $20.42 · planned $0.2M May 21

BCAX Sold 9,200 shares at $23.00 · planned $0.2M Apr 21

BCAX Sold 9,200 shares at $18.52 · planned $0.2M Mar 23

BCAX Sold 2,963 shares at $18.25 · planned $0.1M Mar 4

BCAX Sold 13,555 shares at $18.22 · planned $0.2M Mar 3

BCAX Sold 1,882 shares at $18.15 · planned $0.0M Jan 22

BCAX Sold 9,200 shares at $18.31 · planned $0.2M Dec 22

BCAX Sold 17,795 shares at $18.55 · planned $0.3M Nov 24

BCAX Sold 605 shares at $18.15 · planned $0.0M Nov 21

BCAX Sold 6,415 shares at $18.23 · planned $0.1M Oct 9

BCAX Sold 5,627 shares at $18.21 · planned $0.1M Oct 8

BCAX Sold 18,244 shares at $18.22 · planned $0.3M Oct 7

BCAX Sold 6,514 shares at $18.17 · planned $0.1M Oct 6

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.